Cite
HARVARD Citation
Trojan, B. et al. (2013). The Clinical Usefulness of Nuclear Matrix Protein-22 in Patients with End-Stage Renal Disease and Microscopic Hematuria. Renal failure. pp. 72-76. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Trojan, B. et al. (2013). The Clinical Usefulness of Nuclear Matrix Protein-22 in Patients with End-Stage Renal Disease and Microscopic Hematuria. Renal failure. pp. 72-76. [Online].